Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · BioLife Solutions (BLFS)

BioLife Solutions appoints Tony J. Hunt to board, effective January 2, 2025

Neutral Impact 2 of 5 leadership Written later

BioLife Solutions' board appointed Tony J. Hunt, Executive Chairman of Repligen Corporation, as a director effective January 2, 2025, and as a member of the Audit Committee. His appointment increases the board to six members and is described as independent under Nasdaq rules.

Key points

  • Tony J. Hunt joins the board effective January 2, 2025 and will serve on the Audit Committee.
  • Hunt has been Executive Chairman of Repligen since September 2024 and previously served as its CEO from May 2015.
  • Hunt will receive the same compensation as the company's other non-employee directors, per the 2024 proxy statement filed June 5, 2024.
  • The company announced the appointment in a press release dated December 16, 2024.

The filing

CompanyBioLife Solutions (BLFS)
Form8-K, current report
Filed with the SECDec 20, 2024, 4:31 PM ET
Accession number0001628280-24-052235

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 2:07 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on December 20, 2024.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.